Literature DB >> 28127833

Blastocoele re-expansion time in vitrified-warmed cycles is a strong predictor of clinical pregnancy outcome.

Ruoyun Lin1, Guixue Feng1, Jinhui Shu1, Bo Zhang1, Hong Zhou1, Xianyou Gan1, Caizhu Wang1, Huanhua Chen1.   

Abstract

AIM: To assess the predictive value of blastocoele re-expansion time in clinical pregnancy outcome in vitrified-warmed cycles.
METHODS: Data on 468 single vitrified-thawed blastocyst transfer cycles (in patients aged <38 years) carried out from January 2012 through December 2012, at the Reproductive Medicine Center, Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, were analyzed. Vitrified-warmed blastocysts were divided into three groups according to blastocoele re-expansion time: group A, <1 h; group B, 1-2 h; and group C, >2 h, and the clinical pregnancy outcomes (i.e. live birth rate, miscarriage rate and occurrence of singleton pregnancies) compared between the groups.
RESULTS: Significant differences were observed in the implantation/clinical pregnancy rate between groups A, B and C (70.10%, 51.76% and 28.74%, respectively, P < 0.01). There was a significant linear decline in this rate with increasing blastocyst re-expansion time. The rate of miscarriage also tended to increase with increasing blastocyst re-expansion time, but the difference was not statistically significant (P > 0.05). Of the pregnant patients, no significant difference was observed in the rates of monozygotic twins and ectopic pregnancy between the three groups. For the newborns, similar live birth, low-birthweight and premature delivery rates were observed between the groups.
CONCLUSIONS: Timing of blastocoele re-expansion in vitrified-warmed cycles is a strong predictor of clinical pregnancy outcome. The faster the re-expansion of the blastocoele, the higher the developmental potential of the blastocysts.
© 2017 Japan Society of Obstetrics and Gynecology.

Entities:  

Keywords:  blastocoele re-expansion time; blastocyst; vitrification; vitrified-warmed cycle

Mesh:

Year:  2017        PMID: 28127833     DOI: 10.1111/jog.13257

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  5 in total

1.  Standardization of Post-Vitrification Human Blastocyst Expansion as a Tool for Implantation Prediction.

Authors:  Anat Hershko-Klement; Shaul Raviv; Luba Nemerovsky; Tal Rom; Ayelet Itskovich; Danit Bakhshi; Adrian Shulman; Yehudith Ghetler
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.241

2.  Effect of different artificial shrinkage methods, when applied before blastocyst vitrification, on perinatal outcomes.

Authors:  Caizhu Wang; Guixue Feng; Bo Zhang; Hong Zhou; Jinhui Shu; Ruoyun Lin; Huanhua Chen; Zhulian Wu
Journal:  Reprod Biol Endocrinol       Date:  2017-04-26       Impact factor: 5.211

3.  Recent developments in genetics and medically-assisted reproduction: from research to clinical applications†‡.

Authors:  J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek
Journal:  Hum Reprod Open       Date:  2017-12-04

4.  The impact of post-warming culture duration on clinical outcomes of vitrified-warmed single blastocyst transfer cycles.

Authors:  Ji Young Hwang; Jae Kyun Park; Tae Hyung Kim; Jin Hee Eum; HaengSeok Song; Jin Young Kim; Han Moie Park; Chan Woo Park; Woo Sik Lee; Sang Woo Lyu
Journal:  Clin Exp Reprod Med       Date:  2020-11-10

Review 5.  Recent developments in genetics and medically assisted reproduction: from research to clinical applications.

Authors:  J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.